The role of exosomes in cancer biology by shedding light on their lipid contents.

Biomarkers Cancer Exosomes Lipids Microvesicles

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 12 07 2023
revised: 30 08 2023
accepted: 08 09 2023
pubmed: 29 9 2023
medline: 29 9 2023
entrez: 28 9 2023
Statut: ppublish

Résumé

Exosomes are extracellular bilayer membrane nanovesicles released by cells after the fusion of multivesicular bodies (MVBs) with the plasma membrane. One of the interesting features of exosomes is their ability to carry and transfer various molecules, including lipids, proteins, nucleic acids, and therapeutic cargoes among cells. As intercellular signaling organelles, exosomes participate in various signaling processes such as tumor growth, metastasis, angiogenesis, epithelial-to-mesenchymal transition (EMT), and cell physiology such as cell-to-cell communication. Moreover, these particles are considered good vehicles to shuttle vaccines and drugs for therapeutic applications regarding cancers and tumor cells. These bioactive vesicles are also rich in various lipid molecules such as cholesterol, sphingomyelin (SM), glycosphingolipids, and phosphatidylserine (PS). These lipids play an important role in the formation, release, and function of the exosomes and interestingly, some lipids are used as biomarkers in cancer diagnosis. This review aimed to focus on exosomes lipid content and their role in cancer biology.

Identifiants

pubmed: 37769395
pii: S0344-0338(23)00513-7
doi: 10.1016/j.prp.2023.154813
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154813

Informations de copyright

Copyright © 2023. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Authors declare no conflict of interest.

Auteurs

Parisa Fayyazpour (P)

Department of Clinical Biochemistry, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran; Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.

Ali Fayyazpour (A)

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Khadijeh Abbasi (K)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Yosra Vaez-Gharamaleki (Y)

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mohammad-Sadegh Soltani Zangbar (MS)

Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mortaza Raeisi (M)

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Amir Mehdizadeh (A)

Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: mehdizadeha@tbzmed.ac.ir.

Classifications MeSH